Thus, iCPAGdb and subsequent colocalization analysis support a model where ABO regulates CD209 protein levels to impact COVID-19 risk, though much future experimental and clinical studies will be required to fully test this hypothesis (Fig. 4d). The gene discussed is ABO; the disease is COVID-19.